Daiichi Asubio Pharma Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Daiichi Asubio Pharma Co., Ltd..The latest application filed is for "pharmaceutical compositions for preventing or treating th1-mediated immune diseases".

Company Profile

0.5.5

Daiichi Asubio Pharma Co., Ltd. - 9-11, Akasaka 2-chome, Minato-ku Tokyo JP
Daiichi Asubio Pharma Co., Ltd. - Tokyo JP
Daiichi Asubio Pharma Co., Ltd. - Orix Akasaka 2-chome Building 3F, 9-11 Akasaka 2 Tokyo JP
DAIICHI ASUBIO PHARMA CO., LTD. -
Daiichi Asubio Pharma Co., Ltd - 9-11, Akasaka 2-chome, Minato-ku Tokyo JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions for Preventing or Treating Th1-Mediated Immune Diseases App 20070270337 - Hori; Toshiyuki	2007-11-22
Quinazoline derivatives and pharmaceutical applications thereof Grant 7,169,951 - Fukami , et al. January 30, 2	2007-01-30
Method of growing myocardial cells App 20070009496 - Adachi; Mimi ; et al.	2007-01-11
Method for producing a modified peptide Grant 7,138,489 - Minamitake , et al. November 21, 2	2006-11-21
Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof App 20060178401 - Takemoto; Naohiro ; et al.	2006-08-10
Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component Grant 7,087,248 - Minamitake , et al. August 8, 2	2006-08-08
Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof Grant 7,067,533 - Takemoto , et al. June 27, 2	2006-06-27
Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors App 20060128728 - Inoue; Hidekazu ; et al.	2006-06-15
Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors App 20060128707 - Inoue; Hidekazu ; et al.	2006-06-15
Process for producing (dioxolenon-4-yl)methyl ester derivative Grant 7,041,820 - Watai , et al. May 9, 2	2006-05-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.